Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Padmanee Sharma, MD is an oncologist in Houston, Texas. She is currently licensed to practice medicine in Texas, Florida, and Oklahoma. She is a Professor at Division of.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2000 - 2004
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1998 - 2000
Pennsylvania State University College of MedicineClass of 1998
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2004 - 2026
OK State Medical License 2020 - 2021
NY State Medical License 1999 - 2005
Publications & Presentations
PubMed
- 1 citationsImmune checkpoint inhibitors plus debulking surgery for patients with metastatic renal cell carcinoma: clinical outcomes and immunological correlates of a prospective ...Sangeeta Goswami, Jianjun Gao, Sreyashi Basu, Daniel D Shapiro, Jose A Karam
Nature Communications. 2025-02-21 - 2 citationsTissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma.Michael LaPelusa, Shadi Chamseddine, Hop Sanderson Tran Cao, Lianchun Xiao, Elshad Hasanov
Oncology. 2025-01-01 - 13 citationsNext-generation combination approaches for immune checkpoint therapy.Sangeeta Goswami, Kristen E Pauken, Linghua Wang, Padmanee Sharma
Nature Immunology. 2024-12-01
Press Mentions
MD Anderson Research Highlights for May 21, 2025May 21st, 2025- Breakthrough Discoveries from MD Anderson: Top Research Highlights of May 21, 2025May 21st, 2025
- NEUVOGEN Appoints James P. Allison, Ph.D. And Padmanee Sharma, M.D., Ph.D to Its Scientific Advisory BoardApril 16th, 2025
- Join now to see all
Grant Support
- Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC)UNIVERSITY OF TX MD ANDERSON CAN CTR2023–2028
